Article information
Full text is only aviable in PDF
Bibliografía
[1.]
T. Le Chevalier, R. Arriagada, E. Quoix, P. Ruffie, M. Martin, M. Tarayre, et al.
Radiotherapy alone vs combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
J Natl Cancer Inst, 83 (1991), pp. 417-423
[2.]
B. Enami.
Three-dimensional conformal radiation therapy in bronchogenic carcinoma.
Semin Radiat Oncol, 6 (1996), pp. 92-97
[3.]
C. Scott, et al.
Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small-cell lung cancer.
Lung Cancer, 17 (1997), pp. S59-S74
[4.]
M. Werner-Walsik, C. Scott, J.D. Cox, W.T. Sanse, R.W. Byhardt, S. Asbell, et al.
Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced nonsmall- cell lung cancer (LA-nSCLC): identification of five groups with different survival.
Int J Radiat Oncol Biol Phys, 48 (2000), pp. 1475-1482
[5.]
M. Rotman, H. Aziz, T.H. Wasserman.
Principles and practice of radiation oncology, 3.a, pp. 705-722
[6.]
C.A. Perez, P.W. Grisby, C.K.S. Chao.
Chemotherapy and irradiation in locally advanced squamous cell carcinoma of the uterine cervix.
Semin Radiat Oncol, 7 (1997), pp. 45-65
[7.]
D.I. Rosenthal, D.A. Pistenmaa, E. Glatstein.
A review o neoadjuvant chemotherapy for head and neck cancer: partially shkrunken tumors may be both leaner and meaner.
Int J Radiat Oncol Biol Phys, 28 (1994), pp. 315-320
[8.]
J.F. Flower, M. Lindstrom.
Loss of local control with prolongation in radiotherapy.
Int J Radiat Oncol Biol Phys, 23 (1992), pp. 457-467
[9.]
International collaboration of trialists.
Neoadjuvant cisplatin, metotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial.
Lancet, 354 (1999), pp. 533-540
[10.]
R.S. Pritchard, S.P. Anthony.
Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable non-small-cell lung cancer. A meta-analysis.
Ann Intern Med, 125 (1996), pp. 723-729
[11.]
Group Non-small Cell Lung Cancer Collaborative.
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials.
Br Med J, 311 (1995), pp. 899-909
[12.]
P. Marino, A. Preatoni, A. Cantoni.
Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis.
Cancer, 76 (1995), pp. 593-601
[13.]
J.S. Lee, C. Scott, R. Komaki, F.V. Fossella, G.S. Dundas, S. McDonald, et al.
Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncolgy Group protocol 91-06.
J Clin Oncol, 14 (1996), pp. 1055-1064
[14.]
J.S. Lee, R. Komaki, F.V. Fossella, B.S. Glisson, W.K. Hong, J.D. Cox.
A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5 year follow-up period.
Int J Radiat Oncol Biol Phys, 42 (1998), pp. 479-486
[15.]
R.O. Mirimanoff, D. Moro, M. Bolla, G. Michel, C. Brambilla, B. Mermillod, et al.
Alternating radiotherapy and chemotherapy for inoperable stage III non-small-cell lung cancer: long-term results of two phase II GOTHA trials.
Int J Radiat Oncol Biol Phys, 42 (1998), pp. 487-494
[16.]
R. Komaki, C. Scott, D. Ettinger, J.S. Lee, F.V. Fossella, W. Curran, et al.
Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology Group (RTOG) 92-04.
Int J Radiat Oncol Biol Phys, 38 (1997), pp. 149-155
[17.]
W. Sause, P. Kolesar, I.V. Taylor S, D. Johnson, R. Livingston, R. Komaki, et al.
Final results of phase III trial in regionally advanced unresectable non-small-cell lung cancer.
Chest, 117 (2000), pp. 358-364
[18.]
R.O. Dillman, J. Herndon, S.L. Seagren, W.L. Eaton, M.R. Green.
Improve survival in stage III non-small-cell lung cancer: 7-year follow- up of cancer and leukemia Group B (CALGB) 8433 trial.
J Natl Cancer Inst, 88 (1996), pp. 1210-1215
[19.]
M. Saunders, S. Dische, A. Barrett, A. Harvey, D. Gibson, M. Palmar.
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.
Lancet, 350 (1997), pp. 161-165
[20.]
R. Komaki, C.G. Scott, W.T. Sanse, D.H. Johnson, S.G. Taylor, J.S. Lee, et al.
Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous lung cancer: failure patterns by cell type in RTOG 88-08/ECOG4588.
Int J Radiat Oncol Biol Phys, 39 (1997), pp. 537-544
[21.]
K. Furuse, M. Fuknosia, M. Kawahara, H. Nishikawa, Y. Takada, S. Kudoh, et al.
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer.
J Clin Oncol, 17 (1999), pp. 2692-2699
[22.]
B. Jeremic, Y. Shibamoto, L. Acinovic, S. Milisavljevic.
Hyperfractionated radiation therapy with or without concurrent low dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a radomized study.
J Clin Oncol, 14 (1996), pp. 1065-1070
[23.]
M.H. Cullen, L.J. Billingham, C.M. Woodroffe, A.D. Chetiyawardana, N.H. Gowr, R. Joshi, et al.
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
J Clin Oncol, 17 (1999), pp. 3188-3194
[24.]
J.P. Sculier, M. Paesmans, J.J. Lafitte, J. Baumohl, J. Thriaux, O. van Cutsen.
A randomised phase III trial comparing consolidation treatment with further chemotherapy of chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Ann Oncol, 10 (1999), pp. 295-303
[25.]
G. Clamon, J. Herndon, R. Cooper, A.Y. Chang, J. Rosenman, M.R. Green.
Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the cancer and leukemia group B and the Eastern Cooperative Oncology Group.
J Clin Oncol, 17 (1999), pp. 4-11
[26.]
H. Choy, W. Akerley, H. Safran, S. Graziano, C. Chung, T. Williams.
Multiinstitutional phase II trial of paclitaxel. Carboplatin and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
J Clin Oncol, 16 (1998), pp. 3316-3322
[27.]
A. Wallace, H. Choy.
Single-agent paclitaxel and radiation for nonsmall- cell lung cancer.
Semin Radiat Oncol, 9 (1999), pp. 85-89
[28.]
H. Choy, K. LaPorte, E. Knill-Selby, P. Mohr, Y. Shyr.
Esofagitis in combined modality therapy for locally advanced non-small-cell lung cancer.
Semin Radiat Oncol, 9 (1999), pp. 90-96
[29.]
J.E. Dowell, R. Sinard, D.A. Yardley, V. Ariles, M. Machtay, R.S. Weber.
Seven-week continuous infusion paclitaxel concurrent with radiation therapy for locally advanced non-small-cell lung and head and neck cancers.
Semin Radiat Oncol, 9 (1999), pp. 97-101
[30.]
P. Kirkbride, K. Kirbride, K. Gelmon, E. Eisenhauer.
Paclitaxel and concurrent radiotherapy in locally advanced non-small-cell lung cancer: The canadian experience.
Semin Radiat Oncol, 9 (1999), pp. 102-107
[31.]
C.J. Langer.
Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small-cell lung cancer.
Semin Radiat Oncol, 9 (1999), pp. 108-116
[32.]
D. Lau, J. Ryu, D. Gandara, R. Morgan, J. Dorowshow, R. Wilder.
Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small-cell lung cancer.
Semin Radiat Oncol, 9 (1999), pp. 117-120
[33.]
J. Rathman, K.A. Leopold, J.R. Rigas.
Daily paclitaxel and thoracic radiation therapy for non-small-cell lung cancer: Preliminary results.
Semin Radiat Oncol, 9 (1999), pp. 130-135
[34.]
F. Robert, H.A. Childs, S.A. Spencer, D.T. Redden, M.M. Hawkins.
Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advaced non-small-cell lung cancer. analysis of early and late pulmonary morbidity.
Semin Radiat Oncol, 9 (1999), pp. 136-147
[35.]
B. Reckzeh, H. Merte, K.H. Pfluger, R. Pfab, M. Wolf, K. Havemann.
Severe lymfocytopenia and intersticial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-smallcell lung cancer.
J Clin Oncol, 14 (1996), pp. 1071-1076
[36.]
C. Schaake-Koning, W. van der Bogaert, O. Dalesio, J. Festen, J. Hoogenhont, J. van Houtte.
Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.
N Engl J Med, 326 (1992), pp. 524-530
[37.]
E.E. Vokes, et al.
A randomized phase II study of gemcitabine (GEM) or paclitaxel (TXL) or vinorelbine (VNR) as induction chemotherapy (Ind CT) and concomitant chemotherapy (XRT) for unresectable stage III non-small-cell lung cancer (NSCLC). (CALGB study 9431).
Procc ASCO, 18 (1999), pp. A1771
[38.]
J. Viallet, M.A. Brassard, L. Sonhami, J. Ayoub, P. Del Vecchio, H. Kreisman.
A phase I/II trial of neoadyuvant chemotherapy with cisplatin and vinorelbine followed by acelerated radiotherapy for patients with inoperable non-small-cell lung carcinoma.
Cancer, 85 (1999), pp. 2562-2569
[39.]
E. Felip, J.M. Del Campo, R. Bodi, R. Vera, S. Casado, D. Rubio.
Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage IIIb non-small-cell lung cancer patients.
Am J Clin Oncol, 20 (1997), pp. 404-406
[40.]
P. Zatloukal, L. Petruzelka, M. Zemanova, F. Krejbich, L. Havel.
Vinorelbine plus cisplatin and concurrent radiotherapy in advanced non-small-cell lung cancer.
Procc ASCO, 17 (1998), pp. A1947
[41.]
M. Groen HJ, A.H.W. Van der Leest, W.J. Snoek, G.D. Nossent, B. Oosterhuis, H. Nabers.
Phase III study of continuous carboplatin over 6 weeks with radistion vs radiation alone in stage III non-small cell lung cancer (NSCLC) Procc ASCO, 18 (1999), pp. A1797
[42.]
J.F. Bishop, D.L. Ball, J.G. Smith, P. O'Brien, S. Davrs, G. Ryan.
A randomised phase III trial of concurrent carboplatin and twice daily radiotherapy (RT) in locallly advanced non-small-cell lung cancer.
Procc ASCO, 17 (1998), pp. A1785
[43.]
D.R. Gandara, L.C. Lavato, K.S. Albain.
Pathological stage IIIb nonsmall- cell lung cancer (NSCLC): Prolonged survival with consolidation docetaxel following concurrent chemoradiotherapy (SWOG 9504).
9th World Conference on Lung Cancer, pp. 302
[44.]
R.W. Byhardt, C. Scott, W.T. Sanse, B. Emami, R. Komaki, B. Fisher.
Response, toxivity, failure patterns, and survival in five Radiation Therapy Oncology Groups trials of secuential and/or concurrent chemotheraphy and radiotherapy for locally advanced non-smallcell carcinoma of the lung.
Int J Radiat Oncol Biol Phys, 42 (1998), pp. 469-478
[45.]
J.A. Bonner, W.L. McGinnis, P.J. Stella, R.F. Marschke, J.A. Sloan, E.G. Shaw.
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced non-small-cell lung carcinoma.
Cancer, 82 (1998), pp. 1037-1048
[46.]
R.W. Byhardt.
Toxicities in RTOG combined trials for inoperable non-small-cell lung cancer.
Oncology, 13 (1999), pp. 116-120
[47.]
A.L. Uitterhoeve, J.S. Belderbos, M.G. Koolen, P.J. van der Vaart, P.T. Rodrigus, J. Benraadt.
Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small-cell lung cancer: results of the EORTC 08912 phase I/II study.
Eur J Cancer, 36 (2000), pp. 592-600
[48.]
T.J. Robnett, M. Machtay, E.F. Vines, M.G. McKenna, K.M. Algazy, W.G. McKenna.
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
Int J Radiat Oncol Biol Phys, 48 (2000), pp. 89-94
[49.]
R.B. Giesler.
Assessing the quality of life of patients with cancer.
Curr Probl Cancer, 24 (2000), pp. 53-92
[50.]
K. Kubota, K. Furnse, M. Kawahara, N. Kodama, M. Yamamoto, M. Ogawara.
Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.
J Clin Oncol, 12 (1994), pp. 1547-1552
[51.]
Le Chevalier T, Le Chevalier T, Arriagada R, Tarayre M, Lacombe-Terrier MJ, Laplanche A, Quoix E. Significant effect of adju
Copyright © 2001. Sociedad Española de Neumología y Cirugía Torácica
